Corrigendum to “A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis” [Genes &amp; Diseases 11 (2024) 479–494]

Yanran Bi; Ruiling Zheng; Jiahao Hu; Ruiqing Shi; Junfeng Shi; Yutao Wang; Peng Wang; Wenyi Jiang; Gyudong Kim; Zhiguo Liu; Xiaokun Li; Li Lin

doi:10.1016/j.gendis.2023.101168

您当前的位置：

首页 >

文章列表页 >

Corrigendum to “A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis” [Genes & Diseases 11 (2024) 479–494]

Erratum | 更新时间：2024-02-04

- Corrigendum to “A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis” [Genes & Diseases 11 (2024) 479–494]
- Corrigendum to “A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis” [Genes & Diseases 11 (2024) 479–494]
- Genes & Diseases 2024年11卷第3期
- 作者机构：
  
  1. School of Pharmaceutical Science, Wenzhou Medical University,Wenzhou,China,325035
  2. Zhejiang Lab for Regenerative Medicine, Oujiang Laboratory,Wenzhou,China,325035
  3. Department of Dermatology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine,Wenzhou,China,325000
  4. College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju 61186, Republic of Korea
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.101168
  中图分类号：
- 纸质出版日期：2024，
  
  网络出版日期：2024-5-1，
扫描看全文
Yanran Bi, Ruiling Zheng, Jiahao Hu, 等. Corrigendum to “A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis” [Genes & Diseases 11 (2024) 479–494][J]. Genes & Diseases, 2024,11(3).

Yanran Bi, Ruiling Zheng, Jiahao Hu, et al. Corrigendum to “A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis” [Genes & Diseases 11 (2024) 479–494][J]. Genes & Diseases, 2024,11(3).
Yanran Bi, Ruiling Zheng, Jiahao Hu, 等. Corrigendum to “A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis” [Genes & Diseases 11 (2024) 479–494][J]. Genes & Diseases, 2024,11(3). DOI： 10.1016/j.gendis.2023.101168.

Yanran Bi, Ruiling Zheng, Jiahao Hu, et al. Corrigendum to “A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis” [Genes & Diseases 11 (2024) 479–494][J]. Genes & Diseases, 2024,11(3). DOI： 10.1016/j.gendis.2023.101168.

摘要

Abstract

关键词

Keywords

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据

Corrigendum to “A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis” [Genes & Diseases 11 (2024) 479–494]

Corrigendum to “A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis” [Genes & Diseases 11 (2024) 479–494]

DOI：10.1016/j.gendis.2023.101168

摘要

Abstract

关键词

Keywords

references